Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
10.1016/j.ejbas.2018.06.001 52 EnginS.BarutE
Ipamorelin + CJC-1295 Stack: Evidence, Mechanism, and Protocol At a glance Drug class / Growth hormone secretagogue (GHRP) + Growth hormone-releasing hormone analogue (GHRH analogue) Ipamorelin receptor target / Ghrelin receptor (GHSR-1a), selective, no cortisol or prolactin spike CJC-1295 receptor target / GHRH receptor (GHRHR) on pituitary somatotrophs Combination mechanism / GHRP + GHRH co-stimulation raises GH pulse amplitude 2-to-10-fold over either agent alone in animal models Typical ipamorelin dose / 100-300 mcg subcutaneous injection, 1-3x daily Typical CJC-1295 (no DAC) dose / 100-300 mcg subcutaneous injection, timed with ipamorelin Typical CJC-1295 with DAC dose / 1,000-2,000 mcg subcutaneous injection, once weekly Primary evidence level / Mechanistic + animal + one Phase II RCT (CJC-1295)
Bioactivation of luteolin by tyrosinase selectively inhibits glutathione S-transferase [PMID: 26279214] Laboratory literature summary: Bioactivation of luteolin by tyrosinase selectively inhibits glutathione S-transferase
People with certain conditions, such as severe kidney disease or allergies to B12 components, should discuss suitability with their provider
Available Flavor Blueberry Tartly , a refreshing and sweet blueberry taste
US$ 24.91
US$ 25.85
US$ 28.04
